菌性大动脉动脉瘤的内血管治疗:欧洲多中心研究

Karl Sörelius¹, Kevin Mani¹, Martin Björck¹+28

• ¹From the Institution of Surgical Sciences, Department of Vascular Surgery, Uppsala University, Sweden (K.S., K.M., M.B., A.W.); Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic (P.S.); Department of Vascular Surgery, Karolinska Hospital, Stockholm, Sweden (C.-M.W.); Department of Vascular Surgery, Guy's & St. Thomas' Hospital, London, United Kingdom (R.E.C., P.T., O.L.); St. George's Vascular Institute, London, United Kingdom (M.T., J. Brownrigg); Department of Vascular Surgery, Royal Free London NHS Foundation Trust, London, United Kingdom (K.I., M.D.); Regional Vascular Unit, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom (M.P.J., U.J.); Department of Cardiovascular Sciences and the NIHR Leicester Cardiovascular Biomedical Research Unit, University of Leicester, Leicester, United Kingdom (M.B.); Clinic for Cardiovascular Surgery, University Hospital Zürich, Zürich, Switzerland (Z.R., D.M.); Department of Vascular Surgery, University of Cologne, Cologne, Germany (J. Brunkwall, M.G.); Department for Vascular Medicine, University Heart Center, University Hospital Eppendorf Hamburg, Hamburg, Germany (T.K.); Division of Vascular Surgery, University of Nice-Sophia Antipolis, Nice, France (E.J.-B.); Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands (F.M., P.B.); Department of Vascular Surgery, Attikon University Hospital, Athens, Greece (C.D.L., K.G.M.); Department of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden (M.L., K.R.); and Department of Cardiothoracic and Vascular Surgery, Örebro University Hospital, Örebro, Sweden (T.L., A.P.).+1